Association between disease activity and clinico-laboratory parameters in Systemic Lupus Erythematosus patients in Hospital Universiti Sains Malaysia: a retrospective study

Nur Aishah Nadirah Mohd Salihin; Wan Majdiah Wan Mohamad; Ummul Aqeela Balqees Mohamed Thaha; Mohamad Arif  Awang Nawi; Mohd Jazman Che Rahim

doi:10.31436/ijohs.v6i1.338

Authors

Nur Aishah Nadirah Mohd Salihin School of Dental Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Malaysia.
Wan Majdiah Wan Mohamad School of Dental Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Malaysia & Hospital Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Kelantan.
Ummul Aqeela Balqees Mohamed Thaha School of Dental Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Malaysia & Hospital Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Kelantan.
Mohamad Arif Awang Nawi School of Dental Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Malaysia.
Mohd Jazman Che Rahim Internal Medicine, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Kelantan, Malaysia & Hospital Universiti Sains Malaysia, Kubang Kerian, 16150 Kota Bharu, Kelantan.

DOI:

https://doi.org/10.31436/ijohs.v6i1.338

Keywords:

clinical parameters, disease activity, laboratory parameters, systemic lupus erythematosus

Abstract

Systemic Lupus Erythematosus (SLE) is a prototypic autoimmune disease with multi-system involvement. The clinical manifestations and laboratory parameters in SLE patients vary depending upon the disease severity. SLE affects many organs such as skin, brain, and joints, thus affecting the clinical and laboratory parameters of the patients. This study aims to determine the association between the disease activity and clinico-laboratory parameters among SLE patients at Hospital Universiti Sains Malaysia. A total of 32 medical records of SLE patients from 2010 to 2023 were retrieved. The data of clinical and laboratory parameters were obtained and analysed using SPSS 27.0. Demographic data was analysed descriptively, and the Chi square test was used to evaluate the association between SLE disease activity and the clinico-laboratory parameters. We expect the most common symptoms in SLE include arthritis, malar rash, oral ulcer, and increase anti-dsDNA particularly in active SLE. This study showed the most common symptoms were arthritis (n=14;43.8%) followed by oral ulcer (n=10;31.3%). High level of anti-nuclear antibodies (ANA) was found in 21 patients (65.6%) while 18 (56.3%) patients had elevated erythrocyte sedimentation rate (ESR). Sixteen (50.0%) patients demonstrated low serum C3 and C4 levels. Significant associations were found between the disease activity and arthritis (p=0.033), oral ulcer (p=0.002), prolonged fever (p=0.001), ANA level (p=0.009), and anti-dsDNA level (p=0.022). Arthritis was found to be the most frequent symptoms in SLE patients. High level of ANA, increased ESR and low serum complement levels correlates well with active disease. In conclusion, active SLE patients were more frequently presented with arthritis, oral ulcer, prolonged fever, and demonstrated high ANA and anti-dsDNA levels.

References

Adamichou, C., & Bertsias, G. (2017). Flares in Systemic Lupus Erythematosus: diagnosis, risk factors and preventive strategies. Mediterranean Journal of Rheumatology, 28(1). https://doi.org/10.31138/mjr.28.1.4

Al-Mughales, J. A. (2022). Anti-nuclear antibodies patterns in patients with Systemic Lupus Erythematosus and their correlation with other diagnostic immunological parameters. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.850759

Aringer, M., Costenbader, K. H., Daikh, D.I., Brinks, R., Mosca, M. Ramsey-Goldman, R. et al. (2019). 2019 EULAR/ACR Classification for Systemic Lupus Erythematosus. Arthritis & Rheumatology, 71(9), 1400-1412. https://doi.org/10.1002%2Fart.40930

Ayano, M., Horiuchi, T. (2023). Complement as a biomarker for Systemic Lupus Erythematosus. Biomolecules, 13(2).

Ceccarelli, F., Govoni, M., Piga, M., Cassone, G., Cantatore, F. P., Olivieri, G., et al. (2022). Arthritis is Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium. Journal of Clinical Medicine, 11(20), 6016. doi: 10.3390/jcm11206016

Chanprapaph, K., Tubtieng, I., Pratumchat, N., Thadanipon, K., Rattanakaemakorn, P., & Suchonwanit, P. (2021). Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset Systemic Lupus Erythematosus in 1006 Thai patients. Lupus, 30(5), 785–794. https://doi.org/10.1177/0961203321991920

García-Ríos, P., Pecci-Lloret, M. P., & Oñate-Sánchez, R. E. (2022). Oral manifestations of Systemic Lupus Erythematosus: a systematic review. International Journal of Environmental Research and Public Health, 19(19), 11910. https://doi.org/10.3390/ijerph191911910

Golder, V., & Tsang-A-Sjoe, M. W. P. (2020). Treatment target in SLE: remission and low disease activity state. Rheumatology, 59 (5), v19-v28.

Guéry, J.-C. (2019). Why is systemic lupus erythematosus more common in women? Joint Bone Spine, 86(3), 297–299. https://doi.org/10.1016/j.jbspin.2018.12.004

Hammoudeh, M., Al-Momani, A., Sarakbi, H., Chandra, P., & Hammoudeh, S. (2018). Oral manifestations of Systemic Lupus Erythematosus patients in Qatar: a pilot study. International Journal of Rheumatology, https://doi.org/10.1155/2018/6052326

Ilias, I. M., Allamani Ali, J. M., Nik Ismail, N. Z. A., Rostenberghe, H. V., & Ab Rahman, A. (2017). Pediatric Systemic Lupus Erythematosus (SLE) manifestations and outcomes in a tertiary Hospital. Lupus, 2(1). https://doi.org/10.35248/2684-1630.17.2.123

Jasmin, R., Sockalingam, S., Cheah, T., & Goh, K. (2013). Systemic lupus erythematosus in the multiethnic Malaysian population: disease expression and ethnic differences revisited. Lupus, 22(9), 967–971. https://doi.org/10.1177/0961203313496299

Koelmeyer, R., Nim, H.T., Nikpour, M., Sun, Y.B., Kao, A., Guenther, O., et al. (2019). High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus. Lupus Science & Medicine. 7(1).

Narváez, J. (2020). Review: Systemic Lupus Erythematosus. Medicina Clinica, 155 (11), 494-501. https://doi.org/10.1016/j.medcli.2020.05.009

Nazri, S., Wong, K. K., Hamid, W. (2018). Pediatric systemic lupus erythematosus. Retrospective analysis of clinic-laboratory parameters and their association with Systemic Lupus Erythematosus Disease Activity Index score. Saudi Medical Journal, 39 (6), 627-631. https://doi.org/10.15537%2Fsmj.2018.6.22112

Orme, M.E., Voreck, A., Aksouh, R., Schreurs, M.W.J. (2022). Anti-dsDNA testing specificity for Systemic Lupus Erythematosus: a systematic review. Journal of Applied Laboratory Medicine, 7(1), 221-239. https://doi.org/10.1093/jalm/jfab146

Parker, B. & Bruce, I.N. (2019). Clinical markers, metrics, indices, and clinical trials. Dubois’ Lupus Erythematosus and Related Syndromes, 614-630. https://doi.org/10.1016/B978-0-323-47927-1.00049-9

Petri, M., Orbai, Ana-Maria, Alarcon, G.S., Gordon, C., Merrill, J.T., Fortin, P.R. et al. (2012). Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis and Rheumatism, 64(8), 2677-2686. https://doi.org/10.1002/art.34473

Fosam, H. (2020). Managing dental and orofacial manifestations of Systemic Lupus Erythematosus. Rheumatology Advisor. Retrieved from: https://www.rheumatologyadvisor.com/features/management-of-dental-and-orofacial-manifestations-in-patients-with-systemic-lupus-erythematosus/

Pisetsky, D.S., Spencer, D.M., Lipsky, P.E., & Rovin, B. H. (2018). Assay variation in the detection of antinuclear antibodies in the sera of patients with established SLE. Annals of the Rheumatic Diseases, 77(6), 911-913. https://doi.org/10.1136/annrheumdis-2017-212599

Ramírez Sepúlveda, J.I., Bolin, K., Mofors, J., Leonard, D., Svenungsson, E., Jönsen, A. et al. (2019). Sex differences in clinical presentation of systemic lupus erythematosus. Biology of Sex Differences, 10(1). https://doi.org/10.1186/s13293-019-0274-2

Shamim, R., Farman, S., Batool, S., Anwer Khan, S. E., & Raja, M. K. H. (2020). Association of systemic lupus erythematosus disease activity index score with clinical and laboratory parameters in pediatric onset systemic lupus. Pakistan Journal of Medical Sciences, 36(3), 467-472. https://doi.org/10.12669/pjms.36.3.1480

Yacoub Wasef, S. Z. (2004). Gender differences in systemic lupus erythematosus. Gender Medicine, 1(1), 12-17. https://doi.org/10.1016/S1550-8579(04)80006-8

Zakeri, Z., Narouie, B. Bakhshipour, A., & Sarabadani, J. (2012). Prevalence of oral manifestations in patient with Systemic Lupus Erythematosus (SLE). Life Science Journal, 9(3), 1307-1311.